Genor Biopharma Holdings (HKG:6998) said its chairman, Guo Feng, resigned due to other business commitments, according to a Friday filing with the Hong Kong bourse.
Separately, the company disclosed that it has appointed Weng Chengyi as its new chief financial officer.
Both changes took effect on Thursday.
Price (HKD): $1.65, Change: $+0.20, Percent Change: +13.79%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments